Celiac & Gluten Sensitivity - Blood Spot

We use only CLIA certified labs for all our testing

Congress passed the Clinical Laboratory Improvement Amendments (CLIA) in 1988 establishing authority to promulgate standards for certain laboratory testing to ensure the accuracy, reliability and timeliness of test results regardless of where or by whom the test was performed.   

“CLIA” is the acronym for the Clinical Laboratory Improvement Amendments of 1988. This law requires any facility performing examinations of human specimens (e.g., tissue, blood, urine, etc.) for diagnosis, prevention, or treatment purposes to be certified by the Secretary of the Department of Health and Human Services.

• Patients who have persistent skin conditions (rash) or ataxia, idiopathic neurological conditions, autoimmune arthritis/ thyroiditis, unexplained weight loss or persistent  gastrointestinal symptoms that are not associated with enteropathogens
• Symptomatic individuals that have tested positive for the  HLA DQ2/DQ8 genotypes
• Patients with symptoms or symptom exacerbation with dietary gluten or re-introduction of gluten after a trial elimination of gluten
• Individuals that have a first degree relative with a diagnosis of CD
• Any child with a history of 3 or more antibiotic-treated cases of gastroenteritis while less than 6 months of age
• Patients on a gluten-inclusive diet who have Type I diabetes, Multiple Sclerosis or schizophrenia
• Individuals on a gluten-inclusive diet who have other laboratory evidence that may be associated with CD:
• Elevated liver function tests
• Bone demineralization
• Evidence of impaired absorption of fat-soluble vitamins, iron, B12 or folic acid